These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38059844)

  • 1. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
    Bobot M
    Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
    Faucher Q; van der Made TK; De Lange E; Masereeuw R
    Eur J Pharm Sci; 2023 Aug; 187():106462. PubMed ID: 37169097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional and cognitive changes in chronic kidney disease.
    Kim DS; Kim SW; Gil HW
    Korean J Intern Med; 2022 May; 37(3):489-501. PubMed ID: 35249316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
    Liabeuf S; Pepin M; Franssen CFM; Viggiano D; Carriazo S; Gansevoort RT; Gesualdo L; Hafez G; Malyszko J; Mayer C; Nitsch D; Ortiz A; Pešić V; Wiecek A; Massy ZA;
    Nephrol Dial Transplant; 2021 Dec; 37(Suppl 2):ii33-ii44. PubMed ID: 34718753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specific impact of uremic toxins upon cognitive domains: a review.
    Franco ÁO; Starosta RT; Roriz-Cruz M
    J Bras Nefrol; 2019; 41(1):103-111. PubMed ID: 30095142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease promotes cerebral microhemorrhage formation.
    Fang C; Lau WL; Sun J; Chang R; Vallejo A; Lee D; Liu J; Liu H; Hung YH; Zhao Y; Paganini-Hill A; Sumbria RK; Cribbs DH; Fisher M
    J Neuroinflammation; 2023 Feb; 20(1):51. PubMed ID: 36841828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis.
    Wakamatsu T; Yamamoto S; Yoshida S; Narita I
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
    Watanabe K; Watanabe T; Nakayama M
    Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.
    Fourdinier O; Glorieux G; Brigant B; Diouf M; Pletinck A; Vanholder R; Choukroun G; Verbeke F; Massy ZA; Metzinger-Le Meuth V; Metzinger L; Group-EUTox OBOTEUTW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Dental Scores and Saliva Uremic Toxins.
    Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease.
    Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F
    Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.